Undifferentiated Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
Conditions: Fallopian Tube Mucinous Adenocarcinoma; Ovarian Seromucinous Carcinoma; Recurrent Fallopian Tube Clear Cell Adenocarcinoma; Recurrent Fallopian Tube Endometrioid Adenocarcinoma; Recurrent Fallopian Tube Transitional Cell Carcinoma; Recurrent Fallopian Tube Undifferentiated Ca rcinoma; Recurrent High Grade Fallopian Tube Serous Adenocarcinoma; Recurrent High Grade Ovarian Serous Adenocarcinoma; Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma; Recurrent Low Grade Ovarian Serous Adenocarcinoma; Recurrent Ovarian Clear Cell Adenocarcinoma; Recurrent Ovaria...
Source: ClinicalTrials.gov - February 5, 2021 Category: Research Source Type: clinical trials

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Conditions: Thyroid Cancer; Anaplastic Thyroid Cancer; Undifferentiated Thyroid Cancer Intervention: Drug: Abemaciclib Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials